Download This Bill in Microsoft Word format
Indicates Matter Stricken
Indicates New Matter
Sponsors: Senators Hembree, Senn and Campsen
Document Path: l:\council\bills\cc\15349vr19.docx
Introduced in the Senate on January 8, 2019
Introduced in the House on January 29, 2019
Last Amended on January 24, 2019
Currently residing in the House Committee on Medical, Military, Public and Municipal Affairs
Summary: Urge the Federal Government to work to remove barriers to conducting research on the use of cannabis to treat medical conditions and illnesses
HISTORY OF LEGISLATIVE ACTIONS
Date Body Action Description with journal page number ------------------------------------------------------------------------------- 12/12/2018 Senate Prefiled 12/12/2018 Senate Referred to Committee on Medical Affairs 1/8/2019 Senate Introduced (Senate Journal-page 119) 1/8/2019 Senate Referred to Committee on Medical Affairs (Senate Journal-page 119) 1/17/2019 Senate Committee report: Favorable with amendment Medical Affairs (Senate Journal-page 4) 1/24/2019 Senate Committee Amendment Adopted (Senate Journal-page 37) 1/24/2019 Senate Adopted, sent to House (Senate Journal-page 37) 1/25/2019 Scrivener's error corrected 1/29/2019 House Introduced (House Journal-page 12) 1/29/2019 House Referred to Committee on Medical, Military, Public and Municipal Affairs (House Journal-page 12)
View the latest legislative information at the website
VERSIONS OF THIS BILL
AS ADOPTED BY THE SENATE
January 24, 2019
S. Printed 1/24/19--S. [SEC 1/25/19 2:20 PM]
Read the first time January 8, 2019.
TO URGE THE FEDERAL GOVERNMENT TO WORK EXPEDITIOUSLY TO REMOVE BARRIERS TO CONDUCTING RESEARCH ON THE USE OF CANNABIS TO TREAT MEDICAL CONDITIONS AND ILLNESSES.
Whereas, the U.S. Food and Drug Administration has recently approved Epidiolex oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome in patients two years of age and older; and
Whereas, the recent U.S. Food and Drug Administration's approval of Epidiolex serves as a reminder that advancing development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies, and controlled clinical trials testing the safety and efficacy of a drug along with careful review through the U.S. Food and Drug Administration's drug approval process is the most appropriate way to bring treatments to patients; and
Whereas, citizens across the country are using cannabis to treat a variety of medical conditions and illnesses, and cannabis is becoming increasingly accessible, despite the dearth of scientific research that exists on its efficacy overall and its efficacy as impacted by dosage amounts, drug interactions, drug composition, and drug side effects; and
Whereas, federal statutory and regulatory barriers have prevented thorough research on the use of cannabis to treat medical conditions and illnesses, and these barriers have undermined the ability of states to obtain clear, well-researched scientific evidence relevant to use of cannabis for medical purposes; and
Whereas, the federal government has a duty to protect its citizens by promoting research on the medicinal value, if any, of cannabis to treat a variety of medical conditions and illnesses; and
Whereas, it is the solemn duty of the states to protect the health and well-being of all people and to propose statutory and regulatory actions to accomplish that end. Now, therefore,
Be it resolved by the Senate, the House of Representatives concurring:
That the General Assembly of the State of South Carolina hereby urges the United States Attorney General and Congress to take immediate and additional steps to promote and actively pursue scientific research and testing into the potential use of cannabis to treat other medical conditions and illnesses by removing the federal statutory and regulatory barriers that prevent these scientific endeavors.
Be it further resolved that copies of this resolution be transmitted to the President of the United States, the United States Attorney General, the President and President Pro Tempore of the United States Senate, and the Speaker and Clerk of the United States House of Representatives and that copies of this resolution also be transmitted to the members of the United States Congress from this State.
This web page was last updated on January 30, 2019 at 9:14 AM